AspirinNot Really for Primary Prevention - Frankly Speaking Ep 248

Published: Nov. 1, 2021, 4:30 a.m.

b'Credits: 0.25 AMA PRA Category 1 Credit\\u2122\\n\\xa0\\nCME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-248\\n\\xa0\\nOverview: Join us to hear a discussion on the important changes the AHA/ACC and USPSTF have made to their positions on the use of aspirin for primary prevention of cardiovascular disease. The organizations note that while aspirin for primary prevention lowers the risk of a myocardial infarction, its harmful effects may outweigh its benefits. Learn the aspirin recommendations for your patients in their 40s, 50s, and 60s who are at higher risk for a cardiovascular event.\\n\\xa0\\nEpisode resource links:\\nNew: https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication\\nOld: https://www.aafp.org/afp/2016/1015/od1.html\\nhttps://www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/aspirin-to-prevent-cardiovascular-disease-and-cancer\\nGuest: Jill M. Terrien PhD, ANP-BC\\n\\xa0\\nMusic Credit: Richard Onorato'